Prediction model and method for hypertrophic choroidal disease

Through the combination of SS-OCT technology and S/H ratio, considering multiple factors, a prediction model for hypertrophic choroidal disease was established, solving the problems of diagnostic bias and traumaticity in the existing technology, and providing efficient and objective predictive indicators , distinguish between normal and diseased people.

CN118919057AActive Publication Date: 2024-11-08BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202410974197.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-08
Estimated Expiration
2044-07-19

AI Technical Summary

Technical Problem

The existing technology lacks scientific and objective diagnostic methods and imaging prediction indicators of hypertrophic choroidal disease, and the diagnosis of hypertrophic choroidal disease is traumatic and inconvenient to operate, and there is little observation on the choroidal structural characteristics of normal people, and it is not effective. Distinguish between normal and diseased people.

Method used

Using the most advanced SS-OCT technology, combined with the comprehensive changes of the Sattler layer and Haller layer, the S/H ratio is used to predict hypertrophic choroidal disease, considering multiple factors such as age, gender, and diopter, establish a multivariate regression model and draw a ROC curve. Determine the predictive model of hypertrophic choroidal disease.

Benefits of technology

It achieves a more objective response to the pathological changes of the large vascular layer in the choroid in the disease, provides high sensitivity and high specificity predictive indicators, can effectively distinguish between normal hypertrophic choroid populations from disease populations, and reduces diagnosis bias.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004954069430000051
    Figure BDA0004954069430000051
  • Figure BDA0004954069430000061
    Figure BDA0004954069430000061
  • Figure BDA0004954069430000062
    Figure BDA0004954069430000062
Patent Text Reader

Abstract

The invention relates to the field of biomedicine, in particular to a hypertrophic choroidal disease prediction model and method. The construction of the prediction model comprises the following steps: S1) data acquisition: selecting a hypertrophic choroidal disease eye, a hypertrophic choroidal normal eye and a non-hypertrophic choroidal normal eye as data acquisition objects, and respectively acquiring the thickness of the choroid in a macular region, the thickness of a blood vessel layer in the choroid and the thickness of a large blood vessel layer of the choroid of the data objects; s2) data processing: calculating a ratio of the thickness of the Sattler layer to the thickness of the Haller layer to obtain an S / H ratio; comparing and analyzing choroid thicknesses and S / H ratios of all age stages and among all groups, and establishing a multiple regression model; and S3) data output: drawing an ROC curve to obtain a hypertrophic choroidal disease prediction model based on the S / H ratio. Compared with the healthy eyes of normal people and hypertrophic choroid people, the eye care composition objectively reflects the healthy eyes of the normal people and hypertrophic choroid people.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine, and in particular to a prediction model and method for hypertrophic choroidal disease. Background Art

[0002] (1) Introduction to basic academic concepts: Physiological structure of the choroid and definition of choroid thickness: The wall of the eyeball is composed of three layers: the outer layer, the middle layer, and the inner layer. The outer layer includes the cornea and the sclera, the middle layer is the uveal tract, i.e., the iris, ciliary body, and choroid, and the inner layer is the retina. The choroid is the rearmost part of the uveal tract and is located between the retina and the sclera. It provides a rich blood supply to the outer layer of the retina and is divided from the inside to the outside into the Bruch's membrane, the choroidal capillary layer, the middle vascular layer (Sattler's layer), the large vascular layer (Haller's layer), and the suprachoroidal space. The retinal pigment epithelium (RPE) is the outermost structure of the retina, and its base is closely connected to the Bruch's membrane of the choroid. Choroidal thickness refers to the distance between the high-reflection area of ​​the Bruch's membrane under the retinal pigment epithelium and the outer boundary of the choroid and sclera when using coherent optical tomography. Since the choroid is mainly composed of blood vessels, under normal circumstances, its thickness will show physiological changes with the degree of vascular filling and the influence of other factors. In addition, since the suprachoroidal space is part of the ocular lymphatic system, its thickness can increase rapidly under stress conditions, and a high leakage state can occur under long-term pathological conditions, causing the choroidal thickness to increase slowly or acutely. Therefore, choroidal thickness can intuitively display the morphological changes of the choroid and can be used as an important imaging indicator for the diagnosis, evaluation of intervention effects, and follow-up monitoring of retinal and choroidal diseases. In addition, as the main source of nutrition for photoreceptor cells, changes in choroidal structure and function also play an important role in the pathogenesis of a variety of retinal and choroidal diseases.

[0003] Pachychoroid spectrum disorders: Pachychoroid spectrum disorders (PCD) are a group of diseases characterized by chronic thickening of the choroid and decompensation of choroidal vascular function. It is a new concept first introduced to China by Professor Zhang Xinyuan's team and Professor Timothy Lai's team in 2015. There are no reports on the diagnostic criteria and risk factors for hypertrophic choroidal disease internationally, and there is no precise quantitative standard for hypertrophic choroid.

[0004] (2) Non-invasive fundus imaging technology provides new ideas for the prediction and diagnosis of hypertrophic choroidal disease: Invasive imaging examinations (such as choroidal angiography) are currently the main method for diagnosing hypertrophic choroidal disease, but they have many defects such as high trauma and inconvenient operation. The use of non-invasive OCT indicators has brought great convenience to the clinical prediction and diagnosis of hypertrophic choroidal disease. The team's research found that hypertrophic choroid also exists in the normal population, and the imaging differentiation between this population and hypertrophic choroidal disease will provide new ideas for the prediction and diagnosis of the disease. However, there are currently few observations on the choroidal structure, especially the imaging characteristics, of the normal population, especially the normal population with hypertrophic choroid. There is no research on the imaging differences between the normal population with hypertrophic choroid and the population with hypertrophic choroidal disease, and there is no clear OCT indicator to predict hypertrophic choroidal disease.

[0005] (3) Existing diagnostic thresholds for thick choroid: There is currently no unified gold standard in the academic community.

[0006] The diagnosis of hypertrophic choroidal disease requires two major elements: 1. Increased choroidal thickness 2. Choroidal vascular dysfunction. Choroidal thickening is an important prerequisite for the diagnosis of hypertrophic choroidal disease. Currently, there is a lack of a standard definition of "hypertrophic choroidal diagnostic value" in the academic community, and there is no objective and reliable diagnostic value to distinguish the thickened choroid in normal people. Manual measurement and OCT automatic measurement are the two main methods for measuring choroidal thickness.

[0007] Currently, most studies use the mean value of the choroid in the population plus or minus the upper limit of the standard deviation as the diagnostic standard for thick choroid, that is, the mean ± standard deviation method: patients with hypertrophic choroidal spectrum disorder (PCD) are included, and the sample choroid mean and standard deviation are calculated. The population with thin choroid is < mean - standard deviation, the population with medium choroid is the mean - standard deviation - mean + standard deviation, and the population with thick choroid is > mean + standard deviation.

[0008] A few studies, such as the bimodal model method, use the choroidal thickness interval as the X-axis and the number of people as the Y-axis to obtain a bimodal graph, and use the trough mean as the dividing line to divide hypertrophic disease and non-hypertrophic disease. Sara Touhami et al. defined choroidal thickness > 395 μm as choroidal thickening, and Richard F Spaide et al. defined disease-free thick choroid as subfoveal choroidal thickness ≥ the 95th percentile of age-corrected choroidal thickness of healthy eyes with no disease history.

[0009] However, these methods do not comprehensively consider the effects of age, gender, refraction, axial length and other physiological factors on choroidal thickness. In particular, a large number of studies have found that choroidal thickness gradually becomes thinner with age, and all these imaging factors need to be corrected. Therefore, diagnosis based solely on the measurement of choroidal thickness will have huge bias and great objective limitations, and cannot be used as an objective standard for diagnosing thick choroid.

[0010] (4) Distribution characteristics of hypertrophic choroid in normal population and risk factors for developing hypertrophic choroidal disease: After considering the influence of multiple factors such as age, refraction, and axial length, the team found that there are also people with thick choroid in the normal population (see the invention patent content below for specific methods). According to the reliable and objective diagnostic threshold of hypertrophic choroid proposed by the team, in normal eyes, thick choroid accounts for 14%-41% in different age groups (our research data, not yet published). However, existing studies have rarely observed the choroid of normal people, and there are even fewer studies on the choroid of normal people with choroidal hypertrophy, especially whether the thick choroid is related to the occurrence of hypertrophic choroidal disease and what are the predictive indicators. These are clinical issues that need to be closely followed in clinical work, but have not yet been answered for the following reasons: 1) Hypertrophic choroidal disease is a new concept proposed in recent years. It was first proposed and reported by our team in China in 2016. Research and cognition in this area are limited. 2) Our team is the most powerful team conducting a series of studies in this area and the most influential research team in the world. Therefore, there are few research results from other teams, and this field is still a "virgin land". 3) Other researchers rarely pay attention to the comparison between the anatomical structure of the choroid of normal people and the pathological changes of related diseases. 4) It is still unknown whether thick choroid will progress to hypertrophic choroidal disease. 5) The current academic community lacks a standard definition of the "diagnostic value of hypertrophic choroid", and there is no objective and reliable diagnostic value to distinguish the thickened choroid in normal people.

[0011] Therefore, whether these hypertrophic choroid eyes are risk factors for the development of hypertrophic choroidal disease has not been studied, nor has there been any long-term follow-up or report. All of the above-mentioned contents are currently blank in the international and domestic research and clinical fields.

[0012] (5) Limitations of existing imaging predictive indicators for hypertrophic choroidal disease: The current gold standard for the diagnosis of hypertrophic choroidal disease is still invasive ICGA and other examinations. There is currently no clear OCT indicator to predict hypertrophic choroidal disease. In the imaging observation of hypertrophic choroidal disease, the thickness of the capillary layer and Sattler layer is considered to be atrophic and thin, while the blood vessels of the Haller layer are dilated and thickened. In previous studies on the OCT imaging characteristics of hypertrophic choroidal disease, researchers proposed the ratio of capillary layer thickness or Sattler layer thickness to choroidal thickness (CC / SFCT ratio, S / SFCT ratio) as a predictive indicator for predicting the occurrence and development of the disease. This study used EDI-OCT and Spectralis OCT scanners to automatically measure the choriocapillaris layer thickness, Sattler layer thickness, and macular choroidal thickness in the PCV disease population. Combining the bimodal pattern method and the mean ± standard deviation method, PCV was subjectively divided into <200μm and >200μm. A pairwise comparison of the hypertrophic and non-hypertrophic groups revealed that the ratio of the capillary layer thickness or Sattler layer thickness to the choroidal thickness (CC / SFCT ratio, S / SFCT ratio) in PCV patients was significantly decreased. However, this study had significant limitations in its results and design. First, the OCT used to measure choroidal thickness in the study was an old model. In addition, the study used a cutoff value with low sensitivity and specificity as the standard for grouping, and did not consider the important role of the medium and large choroidal vascular layer in the occurrence and development of the disease. The study also only compared and analyzed a single hypertrophic choroidal disease (such as CSC or PCV), and did not include a normal population with hypertrophic choroid as a control, nor did it consider the various factors that affect choroidal thickness. Therefore, this ratio cannot objectively represent the changes in the large vascular layer of the choroid during the occurrence and development of the disease, and does not comprehensively consider multiple pathological factors such as choroidal vascular dilation, physical compression, and neovascularization, and cannot be used as a comprehensive evaluation indicator to predict the disease.

[0013] Therefore, the focus of the present invention is to find a scientific and objective method for diagnosing hypertrophic choroid (determine the cut-off value) and imaging predictive indicators for hypertrophic choroidal disease. Summary of the invention

[0014] The purpose of the present invention is to use the most advanced SS-OCT technology (the scanning depth can reach as deep as the sclera and the choroid can be observed in detail), taking into account multiple factors that affect the choroid, such as age, gender, refractive power, etc., combined with the comprehensive changes of the Sattler layer and the Haller layer, and using the S / H ratio to predict hypertrophic choroidal disease.

[0015] The present invention provides a computer device, comprising a memory, a processor, and a computer program stored in the memory, wherein the processor executes the computer program to implement the following steps:

[0016] S1) Data collection: eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects, and the choroidal thickness, Sattler layer thickness and Haller layer thickness of the data objects were collected respectively;

[0017] S2) Data processing: Calculate the ratio of Sattler layer thickness to Haller layer thickness to obtain the S / H ratio; Compare and analyze the choroidal thickness and S / H ratio between different age groups and groups, and correct for age, gender, and refraction to establish a multivariate regression model;

[0018] S3) Data output: Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

[0019] Further, the hypertrophic choroidal disease in step S1) includes: polypoidal choroidal vasculopathy, central serous chorioretinopathy, and neovascular age-related macular degeneration;

[0020] In step S1), the critical value standard for judging whether the choroid is hypertrophic or non-hypertrophic is determined by the following steps:

[0021] S11) selecting eyes with hypertrophic choroidal disease and normal eyes as data collection objects;

[0022] S12) performing age, gender and refractive power matching based on the data of step 1);

[0023] S13) for the matched data, swept source OCT measures the choroidal thickness in the macular area;

[0024] S14) Likelihood ratio analysis was used to determine the cutoff value for hypertrophic choroid.

[0025] Furthermore, in step 3), the judgment criteria of the prediction model of hypertrophic choroidal disease based on the S / H ratio are:

[0026] Eyes with an S / H ratio of <0.27 had a higher risk of CSC; eyes with an S / H ratio of <0.30 had a higher risk of PCV; eyes with an S / H ratio of <0.29 had a higher risk of nAMD.

[0027] The present invention also provides a computer-readable storage medium on which a computer program / instruction is stored. When the computer program / instruction is executed by a processor, the above steps are implemented, specifically:

[0028] S1) Data collection: eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects, and the choroidal thickness, Sattler layer thickness and Haller layer thickness of the data objects were collected respectively;

[0029] S2) Data processing: Calculate the ratio of Sattler layer thickness to Haller layer thickness to obtain the S / H ratio; Compare and analyze the choroidal thickness and S / H ratio between different age stages and groups, and correct for age, gender, and refraction to establish a multivariate regression model;

[0030] S3) Data output: Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

[0031] Furthermore, the hypertrophic choroidal disease in step S1) includes: polypoidal choroidal vasculopathy, central serous chorioretinopathy, and neovascular age-related macular degeneration.

[0032] Furthermore, in step S1), the critical value standard for judging whether the choroid is hypertrophic or non-hypertrophic is determined by the following steps:

[0033] S11) selecting eyes with hypertrophic choroidal disease and normal eyes as data collection objects;

[0034] S12) performing age, gender and refractive power matching based on the data of step 1);

[0035] S13) for the matched data, swept source OCT measures the choroidal thickness in the macular area;

[0036] S14) Likelihood ratio analysis was used to determine the cutoff value for hypertrophic choroid.

[0037] Furthermore, in step 3), the judgment criteria of the prediction model of hypertrophic choroidal disease based on the S / H ratio are:

[0038] Eyes with an S / H ratio of <0.27 have a higher risk of CSC; eyes with an S / H ratio of <0.30 have a higher risk of PCV; eyes with an S / H ratio of <0.29 have a higher risk of nAMD.

[0039] Furthermore, the computer-readable storage medium refers to a carrier for storing data, which may be a floppy disk, a CD, a DVD, a hard disk, a flash memory, a USB flash drive, a CF card, a SD card, an MMC card, a SM card, a memory stick or an xD card.

[0040] The present invention provides a computer program product, comprising a computer program, which implements the above steps when executed by a processor:

[0041] S1) Data collection: eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects, and the choroidal thickness, Sattler layer thickness and Haller layer thickness of the data objects were collected respectively;

[0042] S2) Data processing: Calculate the ratio of Sattler layer thickness to Haller layer thickness to obtain the S / H ratio; Compare and analyze the choroidal thickness and S / H ratio between different age stages and groups, and correct for age, gender, and refraction to establish a multivariate regression model;

[0043] S3) Data output: Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

[0044] The present invention provides a method for constructing a hypertrophic choroidal critical value model, comprising the following steps:

[0045] 1) Select eyes with hypertrophic choroidal disease and normal eyes as data collection objects;

[0046] 2) performing age, gender and refraction matching based on the data in step 1);

[0047] 3) For the matched data, swept-source OCT was used to measure the choroidal thickness in the macular area;

[0048] 4) Likelihood ratio analysis was used to determine the critical value of hypertrophic choroid.

[0049] The present invention provides a method for constructing a prediction model for hypertrophic choroidal disease, comprising the following steps:

[0050] 1) Eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease, and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects;

[0051] 2) respectively collecting the choroid thickness, Sattler layer thickness and Haller layer thickness of the data object in the macular area, and calculating the ratio of the Sattler layer thickness to the Haller layer thickness to obtain the S / H ratio;

[0052] 3) Compare and analyze the choroidal thickness and S / H ratio among different age stages and groups, and correct for age, gender, and refraction to establish a multivariate regression model;

[0053] 4) Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

[0054] 9. The construction method according to claim 1, characterized in that the hypertrophic choroidal disease includes: polypoidal choroidal vasculopathy, central serous chorioretinopathy, and neovascular age-related macular degeneration;

[0055] In step S1), the hypertrophic choroidal critical value obtained in claim 7 is used as the critical value standard for judging whether the choroid is hypertrophic or non-hypertrophic.

[0056] Furthermore, in step 3), the prediction model of hypertrophic choroidal disease based on the S / H ratio is:

[0057] Eyes with an S / H ratio of <0.27 had a higher risk of CSC; eyes with an S / H ratio of <0.30 had a higher risk of PCV; eyes with an S / H ratio of <0.29 had a higher risk of nAMD.

[0058] The present invention uses the most advanced SS-OCT technology, taking into account multiple factors that affect the choroid, such as age, gender, and refractive power, and combines the comprehensive changes of the Sattler layer and the Haller layer to predict hypertrophic choroidal disease using the S / H ratio. It more objectively reflects the pathological changes of the choroidal macrovascular layer in the eyes of patients with hypertrophic choroidal disease compared with the healthy eyes of the normal population and the hypertrophic choroid population. BRIEF DESCRIPTION OF THE DRAWINGS

[0059] Figure 1 Flowchart for determining diagnostic cutoffs for hypertrophic choroid; PCD: hypertrophic choroidal spectrum disorder; PCV: polypoidal choroidal vasculopathy; CSC: central serous chorioretinopathy; nAMD: neovascular age-related macular degeneration.

[0060] Figure 2 Correlation analysis between SFCT and age in normal people (Pearson linear correlation analysis, n=382)A: SFCT is negatively correlated with age (r=-0.34, P<0.001)B: SFCT is negatively correlated with age in males (r=-0.43, P<0.001)C: SFCT is negatively correlated with age in females (r=-0.38, P<0.001)SFCT: subfoveal choroidal thickness.

[0061] Figure 3 The correlation between SFCT and refraction in normal people (Spearman rank correlation analysis, n=382). SFCT was weakly positively correlated with refraction (rs=0.19, P<0.001). SFCT: subfoveal choroidal thickness.

[0062] Figure 4This is the distribution of hypertrophic choroid in normal people of different age groups.

[0063] Figure 5 Distribution of hypertrophic choroid in the normal population.

[0064] Figure 6 Comparison of S / H values ​​at different age stages in normal population. (A) Differences in S / H values ​​of normal population with hypertrophic choroid at three age stages: 20-39 years old, 40-59 years old, and ≥60 years old; (B) Differences in S / H values ​​of normal population with non-hypertrophic choroid at three age stages: 20-39 years old, 40-59 years old, and ≥60 years old; (C) Differences in S / H values ​​of all normal population at three age stages: 20-39 years old, 40-59 years old, and ≥60 years old; S / H value: ratio of the thickness of the Satter layer of the choroid to the Haller layer of the choroid.

[0065] Figure 7 To compare the differences in subfoveal choroidal thickness (SFCT) and S / H ratio among the groups.

[0066] Figure 8 To compare the differences in S / H values ​​between normal subjects with hypertrophic choroid, normal subjects with non-hypertrophic choroid and subjects with hypertrophic choroidal disease at different age stages.

[0067] Fig. 9 The multivariate regression model corrected for age, gender, and refraction and showed that a decreased S / H value was a risk factor for hypertrophic choroidal disease.

[0068] Fig.10 Receiver operating characteristic curve (ROC curve) was used to predict the diagnostic cut-off values ​​of PCV, nAMD, and CSC

[0069] (A) ROC curve of PCV; (B) ROC curve of nAMD; (C) ROC curve of CSC; PCV: polypoidal choroidal vasculopathy; nAMD: neovascular age-related macular degeneration; CSC: central serous chorioretinopathy; AUC: area under the ROC curve and enclosed by the coordinate axis.

[0070] Fig.11 Flowchart for identifying predictors of hypertrophic choroidal disease; PCV: polypoidal choroidal vasculopathy; CSC: central serous chorioretinopathy; nAMD: neovascular age-related macular degeneration; S / H: ratio of Sattler's layer to Haller's layer thickness; OCT: optical coherence tomography. DETAILED DESCRIPTION

[0071] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.

[0072] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0073] This invention adheres to the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Tongren Hospital (approval number: TRECKY2016-054). The subjects were aware of the purpose and methods of this study and voluntarily signed the informed consent before entering the study cohort.

[0074] In the following embodiments, the diagnosis of hypertrophic choroidal disease requires an ophthalmic clinical diagnosis. The patient is diagnosed with choroidal polyposis (PCV), age-related maculopathy (nAMD), or central serous chorioretinopathy (CSC) by ophthalmic clinical examination. The PCV diagnostic criteria are based on the expert consensus of the PCV Working Group of the Asia-Pacific Society of Ophthalmic Imaging in 2020, EVEREST study II, and modified EVEREST criteria; the diagnosis of CSC is based on typical clinical manifestations, fluorescein fundus angiography and choroidal angiography, and typical imaging features of OCT; the diagnosis of nAMD is based on the "Expert Consensus on Neovascular Age-Related Macular Degeneration" published by Spaide et al. in 2019.

[0075] Example 1 Determination of the diagnostic cut-off value of hypertrophic choroid

[0076] 1. Data Analysis of Database

[0077] 1. A total of 504 people (760 eyes) were included in the database. The gender and age information of each person were recorded. The relevant data were measured according to the following method, and the SFCT diagnostic cutoff value of PCD was evaluated based on the likelihood ratio. The data results are shown in Table 1:

[0078]

[0079] Note: (a: independent sample t test; b: χ 2 test; c: Mann-Whitney U test) SFCT: subfoveal choroidal thickness; PCD: hypertrophic choroidal spectrum disease

[0080] The specific operation process is as follows Figure 1 As shown, the following steps are included:

[0081] 1) Routine eye examination:

[0082] All subjects received a comprehensive ophthalmic examination. The naked eye visual acuity and best corrected visual acuity of the examined eyes were tested with the Snellen visual acuity chart. The intraocular pressure of the examined eyes was measured with a fully automatic non-contact tonometer (TX20, Santen Pharmaceutical Co., Ltd., Japan). The anterior segment of the examined eyes, including the external eye, cornea, anterior chamber and lens, was examined with a slit lamp microscope (SL-IE, Topcon, Japan). Tropicamide compound eye drops (Santen Pharmaceutical Co., Ltd., Japan) were used to fully dilate the pupil, and a 12500 binocular indirect ophthalmoscope (Keeler, USA) was used for fundus examination. A CR-1 non-mydriatic color fundus camera (Canon Inc., Japan) was used for color fundus photography.

[0083] 2) Measurement of choroidal thickness in the macular area:

[0084] All eyes were instilled with compound tropicamide eye drops to fully dilate the pupils. The macula was examined using SS-OCT (DRIOCT-1Atlantis scanner, Topcon, Japan) with a scanning range of 9 mm × 9 mm. Twelve high-resolution B-scan images of the choroid passing through the fovea were obtained. The 12 B-scan images were automatically analyzed using Topcon Advanced Boundary Segmentation (TABS) software to form Early Treatment Diabetic Retinopathy Study (ETDRS) rings around the fovea, with radii of 1, 3, and 6 mm, respectively. The choroidal thickness value of the central area of ​​the macula was automatically measured by the examination instrument. Images were obtained and manually assisted by two experienced doctors to correct the automatic measurement errors of the software. The ETDRS zoning divided the scanning area into the central zone (C), the upper inner ring zone (S1), the upper outer ring zone (S2), the nasal inner ring zone (N1), the nasal outer ring zone (N2), the lower inner ring zone (I1), the lower outer ring zone (I2), the temporal inner ring zone (T1) and the temporal outer ring zone (T2). The choroidal thickness of the ETDRS zones was measured respectively. According to the international common method, the SFCT mean value, that is, the measurement value of zone C, was mainly analyzed.

[0085] 3) Quantitative diagnosis of hypertrophic choroid by likelihood ratio test:

[0086] The subjects were divided into 20-39 years old group, 40-59 years old group, 60-79 years old group and ≥80 years old group at intervals of 20 years old. Then, the SFCT of all subjects was stratified from the minimum to the maximum value with an interval of 100 μm. The positive likelihood ratio was calculated based on the number of normal group and disease group at different measurement value intervals. Positive likelihood ratio = (number of eyes in the target measurement value interval of the disease group / total number of eyes in the disease group) / (number of eyes in the target measurement value interval of the normal group / total number of eyes in the normal group). The SFCT measurement value interval with a positive likelihood ratio close to 1 represents the critical value for distinguishing the SFCT of the normal group from the disease group. Within this range, SFCT was further stratified with 50, 25, and 10 μm as units to determine the diagnostic criteria for hypertrophic choroid based on SFCT in different age groups.

[0087] 2. The correlation between age and SFCT in normal people and the comparison of SFCT between different genders. Figure 2 As shown: SFCT of normal people gradually decreases with age, and SFCT is negatively correlated with age (r=-0.34, P<0.001). SFCT of normal male and female people is negatively correlated with age (r=-0.43, P<0.001; r=-0.38, P<0.001) ( Figure 2 ).

[0088] 3. The correlation between normal refraction and SFCT, the results are as follows Figure 3 As shown: SFCT of normal subjects' eyes was weakly positively correlated with refraction. As the refraction increased, SFCT gradually increased (rs=0.19, P<0.001) ( Figure 3 ).

[0089] 4. Analysis of influencing factors of SFCT. The results are shown in Table 2: A multiple linear regression analysis model was established with SFCT as the dependent variable and age, gender and diopter as independent variables. The results showed that age (t = -12.01, P < 0.001; 95% CI: -3.37 to -2.42) and diopter (t = 8.19, P < 0.001; 95% CI: 10.43 to 17.02) were independent influencing factors of SFCT. After controlling for age and diopter, gender was not an independent influencing factor of SFCT (β = -11.76, 95% CI: -25.49 to 1.98, P = 0.093) (Table 2).

[0090]

[0091] 5. Diagnostic cut-off value of hypertrophic choroid: The results of likelihood ratio test showed that the SFCT diagnostic measurement value gradually decreased with increasing age. The SFCT diagnostic likelihood ratios of different age groups are shown in Table 3.

[0092]

[0093] 6. According to the diagnostic values ​​determined in this study, the sensitivity and specificity of the likelihood ratio test and the mean ± standard deviation area under the curve evaluated by the receiver operating curve were significantly higher than those of the latter, especially in PCD and normal population, CSC and normal population, and PCV and normal population (PPCD < 0.001, PCSC < 0.001, PPCV = 0.044) (Table 4).

[0094]

[0095] 7. Comparison of the distribution of hypertrophic choroid and non-hypertrophic choroid in normal people of different ages. The results are shown in Table 5. Figure 4 The results show that the incidence of hypertrophic choroid in normal eyes gradually increases with age. The proportion of eyes with hypertrophic choroid in 20-39 years old, 40-59 years old and ≥60 years old were 14.29% (10 / 70), 24.48% (47 / 192) and 29.89% (55 / 184), respectively. The overall difference between the groups was statistically significant (χ2=6.170, P=0.046; LR=6.579, P=0.037). The proportion of hypertrophic choroid in the ≥60 years old group was significantly higher than that in the 20-39 years old group, and the difference was statistically significant (χ2=5.982, P=0.014; LR=6.479, P=0.011).

[0096]

[0097] Based on the results of the above embodiments, it is concluded that the pachychoroid disease spectrum (PCD) is a group of diseases with chronic thickening of the choroid and decompensation of choroidal vascular function as the basic pathological characteristics. It is a new concept proposed in recent years with the great progress of fundus imaging technology, especially optical coherent tomography (OCT) technology. The accurate measurement of choroidal thickness and the definition of the diagnostic value of hypertrophic choroid are undoubtedly of great significance to the understanding of the pathogenesis of PCD and even the diagnosis and prevention of related diseases. However, there is no method for standardizing and accurately quantifying choroidal thickness parameters internationally. At present, the methods for measuring choroidal thickness with OCT are mainly divided into manual single-point or multi-point measurement and automatic segmentation. Due to different measurement methods, various studies have different definitions of hypertrophic choroid. In order to reduce measurement errors, this study adopts a more objective automatic segmentation method, that is, using the Topcon SS-OCT built-in software to automatically partition the choroid layer according to the ETDRS standard. The ETDRS zoning divides the macula into the central zone, inner ring, and outer ring based on the radius of 1, 3, and 6 mm from the fovea, and further divides the inner and outer rings into four quadrants (superior, inferior, nasal, and temporal). Manual correction can effectively reduce the error caused by single-point measurement. This study mainly analyzed the central zone SFCT mean commonly used internationally under this zoning method, and diagnosed PCD eyes and normal eyes through the likelihood ratio test, adjusting the influence of factors such as age and refraction on the results. In addition, the calculation process of the likelihood ratio combines the two indicators of sensitivity and specificity, which has better clinical application value.

[0098] Example 2

[0099] Study population:

[0100] 1) Total database: A prospective cohort study database of hypertrophic choroidal disease was established (outpatients at Beijing Tongren Eye Center from 2016 to 2022): a total of 468 people (691 eyes), including 82 patients with PCV (97 eyes), 58 patients with nAMD (66 eyes), 51 patients with CSC (61 eyes) and 277 normal healthy subjects (467 eyes);

[0101] 2) Matching database: According to the proportion of case numbers, 55 PCV patients (61 eyes), 38 nAMD subjects (43 eyes), and 45 CSC subjects (50 eyes) were extracted from the above database and matched with 100 normal healthy subjects (120 eyes) in terms of gender and refraction (controlling for gender and matching for refraction);

[0102] 3) Validation database: 300 eyes were randomly selected from the total database to form the validation data set, including 157 normal subjects (179 eyes), 42 PCV patients (44 eyes), 26 nAMD patients (28 eyes), and 27 CSC patients (31 eyes).

[0103] like Fig.11 As shown, the present invention provides a method for determining the diagnostic cut-off value of S / H in each disease group, comprising the following steps: 1) taking normal people with choroidal hypertrophy, normal people without choroidal hypertrophy, and people with hypertrophic choroidal disease as research subjects, 2) measuring the choroidal thickness, Sattler layer thickness, and Haller layer thickness of each research subject in the macular area, 3) comparing and analyzing the choroidal thickness and S / H ratio between different age stages and groups, 4) matching the age, gender, and refractive power of people with hypertrophic choroidal disease with normal people, and establishing a multivariate regression model, 5) drawing a ROC curve to determine the diagnostic cut-off value of S / H in each disease group. The above method is the first to perform imaging analysis with hypertrophic normal people as the control group (a large number of samples can be included), using the most advanced swept source OCT and accurately measuring the S layer and H layer, considering the three major factors affecting the choroidal thickness, the result is more objective, using the ROC curve to find a high-specificity and high-sensitivity index, and for the first time proposing the S / H ratio as an index for predicting hypertrophic choroidal disease.

[0104] 1. Data analysis of the total database

[0105] 1. For a total of 468 people (691 eyes) in the database, the gender and age information of each person was recorded, and the relevant data were measured according to the following method. Some of the data results are shown in Table 6:

[0106] 1) Routine eye examination:

[0107] All subjects received a comprehensive ophthalmic examination. The naked eye visual acuity and best corrected visual acuity of the examined eyes were tested with the Snellen visual acuity chart. The intraocular pressure of the examined eyes was measured with a fully automatic non-contact tonometer (TX20, Santen Pharmaceutical Co., Ltd., Japan). The anterior segment of the examined eyes, including the external eye, cornea, anterior chamber and lens, was examined with a slit lamp microscope (SL-IE, Topcon, Japan). Tropicamide compound eye drops (Santen Pharmaceutical Co., Ltd., Japan) were used to fully dilate the pupil, and a 12500 binocular indirect ophthalmoscope (Keeler, USA) was used for fundus examination. A CR-1 non-mydriatic color fundus camera (Canon Inc., Japan) was used for color fundus photography.

[0108] 2) Measurement of thickness of each layer of choroid in the macular area

[0109] All subjects underwent SS-OCT (DRIOCT1 Atlantis scanner, Topcon Co., Ltd., Tokyo, Japan). Twelve high-resolution B-ultrasound images across the fovea were obtained in radial mode through the macular area, with a scanning range of 9*9 mm. Choroidal thickness was automatically obtained in 9 macular areas by TOPCON Advanced Boundary Segmentation-TABS software. The Early Treatment Diabetic Retinopathy Study Classification (ETDRS) zones divided the macula into 9 areas: a circle with a diameter of 1 mm in the center, 4 inner quarter circles with diameters of 1 mm to 3 mm on the outside, and 4 outer quarter circles with diameters of 3 mm to 6 mm. The thickness of the choriocapillaris layer (10.4 μm) was automatically defined by the OCT software; the boundaries of the Satter layer and Haller layer were determined by the TAB software and then manually adjusted according to the morphological magnification of the choroidal vessels, such as the size of the vascular lumen. Two independent ophthalmologists (QW with 4 and BQ with 6 years of field experience) performed the measurements, manually adjusted the stratification, and acquired the images. Calculate the thickness ratio of the Satter layer to the Haller layer.

[0110]

[0111] Further, the subjects in the total database can be divided into hypertrophic choroid and non-hypertrophic choroid (according to the standards of Table 3 in Example 1), wherein the normal subjects include 92 normal subjects with hypertrophic choroid (140 eyes) and 185 normal subjects with non-hypertrophic choroid (327 eyes), PCV subjects include 40 subjects with hypertrophic choroid PCV (45 eyes) and 42 subjects with non-hypertrophic choroid PCV (52 eyes), nAMD subjects include 12 subjects with hypertrophic choroid nAMD (14 eyes) and 46 subjects with non-hypertrophic choroid nAMD (52 eyes), and CSC subjects include 39 subjects with hypertrophic choroid CSC (46 eyes) and 12 subjects with non-hypertrophic choroid CSC (15 eyes).

[0112] 2. Analyze the proportion of choroidal thickening in normal population at different age groups in the total database. The results are as follows: Figure 5 As shown. Figure 5 It can be seen that the proportion of choroidal thickening in the normal population at different age stages is: 14%-41% of the normal population has choroidal thickening.

[0113] 3. Analyze the differences in S / H values ​​between hypertrophic and non-hypertrophic subgroups of the normal population in the total database. The results are as follows Figure 6 As shown, Figure 6(A) The differences in S / H values ​​of normal people with hypertrophic choroid at three age stages: 20-39 years old, 40-59 years old, and ≥60 years old; (B) The differences in S / H values ​​of normal people with non-hypertrophic choroid at three age stages: 20-39 years old, 40-59 years old, and ≥60 years old; (C) The differences in S / H values ​​of all normal people at three age stages: 20-39 years old, 40-59 years old, and ≥60 years old; S / H value: the ratio of the thickness of the Satter layer of the choroid to the Haller layer of the choroid. Figure 6 It can be seen that there was no statistical difference between the normal group with hypertrophic choroid and the total normal group at 20-39 years old, 40-59 years old, and ≥60 years old (p>0.05); there was a statistical difference between the normal group with non-hypertrophic choroid at 40-59 years old and ≥60 years old (p<0.05).

[0114] 2. Data Analysis of Matching Database

[0115] 1. For the 55 PCV patients (61 eyes), 38 nAMD subjects (43 eyes), and 45 CSC subjects (50 eyes) in the matching database, the gender and age information of each person was recorded, and the relevant data were measured according to the following method. Some data results are shown in Table 7:

[0116]

[0117] Based on the data of each tester in the matching database obtained in the above steps, the differences in subfoveal choroidal thickness (SFCT) and S / H ratio between the groups were compared. The results are as follows: Figure 7 As shown, from Figure 7 It can be seen that there is no statistical difference between hypertrophic normal subjects and hypertrophic PCV and hypertrophic nAMD (p>0.05). The S / H value is statistically different between the hypertrophic normal group and the hypertrophic choroidal disease group (p<0.05).

[0118] 3. Based on the test data of the total database, the differences in S / H values ​​between hypertrophic and non-hypertrophic normal people in various age groups were compared. The results are as follows Figure 8 As shown in A in the figure; Based on the test data of the matching database library, the differences in S / H values ​​between the hypertrophic and non-hypertrophic normal population and the hypertrophic choroidal disease population in each age group were compared. The results are shown in Figure 4As shown in B and C, (A) the difference in S / H value between normal people with hypertrophic choroid and normal people with non-hypertrophic choroid at the age of 20-39 years, 40-59 years and ≥60 years; (B) the difference in S / H value between normal people with hypertrophic choroid and people with hypertrophic choroid disease at the age of 20-39 years, 40-59 years and ≥60 years; (C) the difference in S / H value between normal people with non-hypertrophic choroid and normal people with hypertrophic choroid at the age of 20-39 years, 40-59 years and ≥60 years; S / H value: the ratio of the thickness of the Satter layer of the choroid to the Haller layer of the choroid. From Figure 8 It can be seen that the differences in S / H values ​​between the hypertrophic and non-hypertrophic subgroups of normal subjects and the hypertrophic choroidal disease (PCD) group in each age group: there was no statistical difference between the hypertrophic normal subjects and the non-hypertrophic normal subjects (p>0.05), while there were statistical differences between the total normal subject group and the hypertrophic normal subject group and the hypertrophic choroidal group in the age groups of 40-59 years and ≥60 years, respectively (p>0.05).

[0119] 2. Model establishment (please carefully confirm whether the statement in this part is correct)

[0120] 1. Establishment of multiple regression model

[0121] The effects of age, sex, and refractive error were corrected by multivariate regression analysis to obtain a matched database, with the hypertrophic normal group and all normal groups as reference groups, respectively, to evaluate the relationship between S / H values ​​and PCV, nAMD, and CSC groups. If normal controls were used as the reference analysis group, an odds ratio (OR) > 1 meant that the independent variable was an independent risk factor for the dependent variable (disease), while an OR < 1 meant that the independent variable was a protective factor.

[0122] SPSS statistical software (SPSS, Inc. 22.0, Chicago, IL, USA) was used to correct the effects of age, gender, and refractive power. It was found that a decrease in the S / H value was a risk factor for hypertrophic choroidal disease (i.e., the S / H value was a protective factor for hypertrophic choroidal disease). The ROC curve was drawn to find the critical value of the S / H value, which had high sensitivity and specificity.

[0123] Results of multivariate regression models: After adjusting for age, sex and refractive error, the regression model showed that the S / H ratio was a protective factor for nAMD (OR 0.43, 95% CI 0.30-0.62, p < 0.001), PCV (OR 0.53, 95% CI 0.40-0.71, p < 0.001) and CSC (OR 0.34, 95% CI 0.22-0.52, p < 0.001) compared with normal healthy subjects. Compared with normal subjects with hypertrophic disease, S / H ratio was also a protective factor for nAMD (OR=0.41, 95%CI 0.26-0.63, p<0.001), PCV (OR 0.52, 95%CI 0.36-0.75, p<0.001) and CSC (OR=0.36, 95%CI 0.23-0.57, p<0.001).

[0124] The results are as follows Fig. 9 As shown, Fig. 9 After correcting for age, gender, and refraction in the multivariate regression model, decreased S / H value was a risk factor for hypertrophic choroidal disease. Taking normal subjects as reference, decreased S / H value was a risk factor for PCV (A), nAMD (B), and CSC (C); taking normal subjects with hypertrophic choroid as reference, decreased S / H value was a risk factor for PCV (D), nAMD (E), and CSC (F); PCV: polypoidal choroidal vasculopathy; nAMD: neovascular age-related macular degeneration; CSC: central serous chorioretinopathy; S / H value: ratio of the thickness of the Satter layer of the choroid to the Haller layer of the choroid.

[0125] 2. Drawing of ROC curve and determination of cut-off value

[0126] The cut-off values ​​of S / H ratio for diagnosing different phenotypes of hypertrophic choroidal disease, including CSC, PCV, and nAMD, were determined by ROC curve. The index with high sensitivity and high specificity was selected as the cut-off value on the ROC curve. The cut-off value of S / H ratio for CSC was 0.27 (AUC: 0.79, sensitivity = 0.77, specificity = 0.73); the cut-off value of S / H ratio for PCV was 0.30 (AUC: 0.72, sensitivity = 0.71, specificity = 0.64), and the cut-off value of S / H ratio for nAMD was 0.29 (AUC: 0.76, sensitivity = 0.72, specificity = 0.69).

[0127] ROC curve results: eyes with S / H < 0.27 (AUC: 0.79, sensitivity = 0.77, specificity = 0.73) had a higher risk of CSC, eyes with S / H < 0.30 had a higher risk of PCV (AUC: 0.72, sensitivity = 0.71, specificity = 0.64), and eyes with S / H < 0.29 had a higher risk of nAMD (AUC: 0.76, sensitivity = 0.72, specificity = 0.69).

[0128] like Fig.10 As shown, Fig.10 Receiver operating characteristic curve (ROC curve) was used to predict the diagnostic cut-off values ​​of PCV, nAMD, and CSC. (A) ROC curve of PCV; (B) ROC curve of nAMD; (C) ROC curve of CSC. PCV: polypoidal choroidal vasculopathy; nAMD: neovascular age-related macular degeneration; CSC: central serous chorioretinopathy; AUC: area under the ROC curve and enclosed by the coordinate axis.

[0129] Based on the above results, it can be concluded that: people with an S / H ratio <0.27 have a higher risk of CSC than those with an S / H ratio >0.27; people with an S / H ratio <0.30 have a higher risk of PCV than those with an S / H ratio >0.30; people with an S / H ratio <0.29 have a higher risk of nAMD than those with an S / H ratio >0.29.

[0130] 3. Model Validation

[0131] A validation data set of 300 eyes was randomly selected from the total database, including 157 normal subjects (179 eyes), 42 PCV patients (44 eyes), 26 nAMD patients (28 eyes), and 27 CSC patients (31 eyes). The gender and age information of each person was recorded, and the relevant data were measured according to the following method (see Table 8 for baseline data): the sensitivity of PCV was 70.45%, and the specificity was 66.50%, the sensitivity of nAMD was 67.86%, and the specificity was 69.54%, and the sensitivity of CSC was 77.42%, and the specificity was 74.11%.

[0132]

[0133] Based on the results of the above embodiments, it can be seen that invasive imaging examinations are the main method for diagnosing hypertrophic choroidal disease at present, but they have many defects such as high trauma and inconvenient operation. The use of non-invasive OCT indicators brings great convenience to the clinical prediction and diagnosis of hypertrophic choroidal disease. Since choroidal thickening exists in the normal population, the imaging differentiation between this population and hypertrophic choroidal disease will provide ideas for the prediction and diagnosis of the disease. However, there are currently few observations on the choroidal structure and imaging characteristics of the normal population, especially the normal population with hypertrophic choroid. No one has studied the imaging differences between the normal population with hypertrophic choroid and the population with hypertrophic choroidal disease, and there is no clear OCT indicator to predict hypertrophic choroidal disease. The present invention emphasizes the imaging of gender and refraction on choroidal structure, and proposes that the S / H value is a more stable predictive indicator for PCD disease than choroidal thickness.

[0134] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims.

Claims

1. A computer device comprising a memory, a processor and a computer program stored in the memory, characterized in that: The processor executes the computer program to implement the following steps: S1) Data collection: eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects, and the choroidal thickness in the macular area, the thickness of the choroidal middle vascular layer (Sattler layer) and the thickness of the choroidal large vascular layer (Haller) were collected respectively; S2) Data processing: Calculate the ratio of Sattler layer thickness to Haller layer thickness to obtain the S / H ratio; Compare and analyze the choroidal thickness and S / H ratio between different age groups and groups, and correct for age, gender, and refraction to establish a multivariate regression model; S3) Data output: Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

2. The computer device according to claim 1, characterized in that: The hypertrophic choroidal diseases in step S1) include: polypoidal choroidal vasculopathy, central serous chorioretinopathy, and neovascular age-related macular degeneration; In step S1), the critical value standard for judging whether the choroid is hypertrophic or non-hypertrophic is determined by the following steps: S11) selecting eyes with hypertrophic choroidal disease and normal eyes as data collection objects; S12) performing age, gender and refractive power matching based on the data of step 1); S13) for the matched data, swept source OCT measures the choroidal thickness in the macular area; S14) Likelihood ratio analysis was used to determine the cutoff value for hypertrophic choroid.

3. The computer device according to claim 1, characterized in that: In step 3), the judgment criteria of the prediction model of hypertrophic choroidal disease based on the S / H ratio are: Eyes with an S / H ratio of <0.27 had a higher risk of CSC; eyes with an S / H ratio of <0.30 had a higher risk of PCV; eyes with an S / H ratio of <0.29 had a higher risk of nAMD.

4. A computer-readable storage medium having a computer program / instruction stored thereon, characterized in that: When the computer program / instructions are executed by a processor, the steps described in any one of claims 1-3 are implemented.

5. The computer-readable storage medium according to claim 4, wherein: The computer-readable storage medium refers to a carrier for storing data, which may be a floppy disk, a CD, a DVD, a hard disk, a flash memory, a USB flash drive, a CF card, a SD card, an MMC card, a SM card, a Memory Stick or an xD card.

6. A computer program product comprising a computer program, characterized in that When the computer program is executed by a processor, the steps described in any one of claims 1 to 3 for executing the computer program by the processor are implemented: S1) Data collection: eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects, and the choroidal thickness, Sattler layer thickness and Haller layer thickness of the data objects were collected respectively; S2) Data processing: Calculate the ratio of Sattler layer thickness to Haller layer thickness to obtain the S / H ratio; Compare and analyze the choroidal thickness and S / H ratio between different age stages and groups, and correct for age, gender, and refraction to establish a multivariate regression model; S3) Data output: Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

7. A method for constructing a hypertrophic choroidal critical value model, characterized in that: The steps include: 1) Select eyes with hypertrophic choroidal disease and normal eyes as data collection objects; 2) performing age, gender and refraction matching based on the data in step 1); 3) For the matched data, swept-source optical coherence tomography (OCT) was used to measure the choroidal thickness in the macular area; 4) Likelihood ratio analysis was used to determine the critical value of hypertrophic choroid.

8. A method for constructing a prediction model for hypertrophic choroidal disease, characterized in that: The steps include: 1) Eyes with hypertrophic choroidal disease, eyes with normal hypertrophic choroidal disease, and eyes with normal non-hypertrophic choroidal disease were selected as data collection objects; 2) respectively collecting the choroid thickness, Sattler layer thickness and Haller layer thickness of the data object in the macular area, and calculating the ratio of the Sattler layer thickness to the Haller layer thickness to obtain the S / H ratio; 3) Compare and analyze the choroidal thickness and S / H ratio among different age stages and groups, and correct for age, gender, and refraction to establish a multivariate regression model; 4) Draw the ROC curve and obtain the prediction model of hypertrophic choroidal disease based on the S / H ratio.

9. The construction method according to claim 1, characterized in that: The hypertrophic choroidal diseases include: polypoidal choroidal vasculopathy, central serous chorioretinopathy, neovascular age-related macular degeneration; In step S1), the hypertrophic choroidal critical value obtained in claim 7 is used as the critical value standard for judging whether the choroid is hypertrophic or non-hypertrophic.

10. The construction method according to claim 1, characterized in that: In step 3), the prediction model of hypertrophic choroidal disease based on the S / H ratio is: Eyes with an S / H ratio of <0.27 had a higher risk of CSC; eyes with an S / H ratio of <0.30 had a higher risk of PCV; eyes with an S / H ratio of <0.29 had a higher risk of nAMD.

Citation Information

Patent Citations

  • Comprehensive ophthalmology image system based on sweep frequency source OCT (optical coherence tomography) and acquisition method thereof

    CN114903426A

  • Method for constructing coronary artery disease risk discrimination model based on conventional physical examination indexes

    CN115132363A

  • Choroid thickness evaluation method and device and computer equipment

    CN115797319A

  • Optical coherence tomography choroidal blood vessel layering radiography method

    CN115810004A

  • Method for prediction of the risk of developing choroidal neovascularisation (CNV) in patients with moderate- and high-grade pathological myopia

    RU2704467C1